Reproductive Healthcare Leave Act
The Reproductive Healthcare Leave Act would require covered employers to provide each employee with 96 hours of paid leave at the start of each calendar year. Employees could use that leave for absences related to reproductive health conditions, symptoms tied to those conditions, or reproductive health care procedures. The bill expressly includes uses such as menstruation, endometriosis, dysmenorrhea, adenomyosis, polycystic ovary syndrome, menopause, and perimenopause, as well as medical care, procedures, and preventive screening related to reproductive health.
The leave could also be used for fertility treatments, pregnancy termination, hysterectomies, and vasectomies. Employers would be prohibited from requiring workers to find replacement coverage as a condition of taking the leave, and existing paid leave policies would satisfy the bill if they already provide an equivalent amount of leave for the same reasons and under the same conditions. The bill also bars retaliation, interference, and adverse employment actions based on use of the leave, and it sets notice, recordkeeping, and enforcement requirements modeled in part on the Fair Labor Standards Act.
The bill would create a new federal paid leave entitlement for reproductive health-related absences and would apply to most private employers with 5 or more employees, as well as certain public employers and federal, congressional, and other specified government workplaces. It would add new employer notice obligations, anti-retaliation protections, administrative enforcement authority for the Secretary of Labor, and a private right of action with damages, liquidated damages, attorney’s fees, and equitable relief. The bill also includes rules on regulations, limitations periods, and coordination with existing labor and employment frameworks, while preserving stronger federal, state, local, contractual, and collective bargaining leave rights.
Based on the bill text and the available legislative context, the measure appears to be framed as an employee-protection and public-health bill, with support from a large group of Democratic sponsors and no recorded committee debate or votes in the provided materials. The overall tone of the proposal is affirmative toward expanding paid leave access for reproductive health needs and preventing workplace penalties for using that leave. Because there are no transcripts or vote tallies, there is no documented formal opposition in the supplied record, but the subject matter suggests likely partisan and policy sensitivity around reproductive health and employer mandates.
The main points of potential contention are the scope of the leave mandate, the inclusion of reproductive health procedures and conditions that some may view as controversial, and the burden on employers required to provide 96 hours of paid leave annually. Employers may also object to the anti-replacement rule, recordkeeping obligations, and exposure to private lawsuits and damages. Another possible area of dispute is the bill’s application to public employers and government workplaces, as well as its interaction with existing leave policies, collective bargaining agreements, and state laws that may already regulate paid or unpaid leave.